Key points are not available for this paper at this time.
Design
Review
Caution against abrupt OPV cessation post-eradication; leaves open affordable IPV access strategies for low-income countries.
Polio eradication, like all eradication efforts, is a gamble. If it fails, much of the money spent will have been wasted. If it succeeds, the world will reap a dividend. Success or failure and the magnitude of the dividend depend on a long chain of "weakest links." In this paper I identify these links and explain how the chain can be strengthened. A crucial vulnerability is the current plan to halt vaccination using the live-attenuated oral polio vaccine in the post-eradication era. This weakest link can be strengthened by efforts that lower the cost to poor countries of vaccinating with the inactivated poliovirus vaccine.
No takes yet. Share an insight, caveat, or question.
Scott Barrett (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: